3,4-dihydroxyphenylacetaldehyde has been researched along with hydantoins in 1 studies
Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (hydantoins) | Trials (hydantoins) | Recent Studies (post-2010) (hydantoins) |
---|---|---|---|---|---|
99 | 0 | 50 | 3,404 | 80 | 435 |
Protein | Taxonomy | 3,4-dihydroxyphenylacetaldehyde (IC50) | hydantoins (IC50) |
---|---|---|---|
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.062 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and hydantoins
Article | Year |
---|---|
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone | 2000 |